舒郁胶囊对抑郁情绪模型大鼠不同脑区5-HT_(3B)受体分布与表达的影响
|
摘要
目的:检测抑郁情绪模型大鼠脑区额叶皮质、顶叶皮质、海马和下丘脑相关区域内5-HT_(3B)受体(5-HT_(3B)R)蛋白分布、表达的变化,初步探讨抑郁情绪发病的中枢机制,并研究中药舒郁胶囊对该病证的干预作用。
方法:筛选大鼠进入实验,采用慢性温和应激法(CMS)复制抑郁情绪大鼠模型,以糖水偏好实验、旷场试验和宏观行为表现评价模型,以西药氟西汀为阳性药,采用免疫荧光法检测正常对照组、抑郁情绪模型组、舒郁胶囊给药组和氟西汀西药给药组大鼠额叶皮质、顶叶皮质、海马和下丘脑中5-HT_(3B)R的定位分布,并定量检测海马与下丘脑中5-HT_(3B)R的表达。
结果:与正常组大鼠相比,模型组大鼠体重显著减轻(P<0.01),旷场实验水平得分、垂直得分、旷场实验总分均显著减少(P<0.01),糖水偏好实验糖水摄入量显著减少(P<0.01),大鼠表现出精神萎靡,眼神呆滞,对外界刺激不敏感的状态;而造模并给予舒郁胶囊和氟西汀的大鼠较模型组大鼠体重增长显著(P<0.05),旷场实验三项得分均显著增加(P<0.01),糖水偏好实验中饮糖水量显著增加(P<0.01),但两组之间都没有显著性差异(P>0.05)。免疫荧光结果显示,四组大鼠额叶皮质、顶叶皮质、海马、下丘脑中5-HT_(3B)R的定位分布无显著性差异。与正常组大鼠相比,模型组大鼠海马CA1、CA3与下丘脑VMH区5-HT_(3B)R平均荧光强度(MFI)显著升高(P<0.05或P<0.01),额叶皮质、顶叶皮质5-HT_(3B)R有升高的可能。造模并给予舒郁胶囊和氟西汀治疗的大鼠与模型组相比,海马CA1、CA3与下丘脑VMH区5-HT_(3B)R平均荧光强度(MFI)显著降低(P<0.01),两组间没有显著性差异(P>0.05),额叶皮质、顶叶皮质5-HT_(3B)R有降低的可能。
结论:采用慢性温和应激法可以成功制备抑郁情绪大鼠模型,糖水偏好实验、旷场试验结合宏观行为药理学可有效评价模型。大鼠额叶皮质、顶叶皮质、海马CA1、CA3、下丘脑VMH区5-HT_(3B)R蛋白表达升高可能与抑郁情绪关系密切,可能是抑郁情绪发病的中枢机制之一;中药舒郁胶囊可以有效纠正模型大鼠上述脑区5-HT_(3B)R蛋白表达异常升高的状态,可能是该药治疗抑郁情绪的机制之一。
Objective:Our aim is to detect the relationship between protein location & expression levels of 5-HT_(3B)R in correlated region offrontal cortex , parietal cortex ,hippocampus & hypothalamus of depression emotion model rats, which gives a preliminary discussion on the pathogenesis of depression emotion,as well as studies the effects of Shuyu capsule.
Methods:After being chosen,depression emotion model rats were prepared by using chronicity mild stimulus(CMS)method.And then the rats were evaluated by sucrose preference test,open field test and macro-behavior observation.We used fluoxetine as masculine medicine, detected the 5-HT_(3B)R protein location in parietal cortex, frontal cortex, hippocampus and hypothalamus of rats in the groups including the normal group, depression emotion model group,and the two treatment groups by using immunofluorescence(IF), and detected the mean fluorescence intensity (MFI) in CA1、CA3 of hippocampus and in ventromedial hypothalamic area(VMH)of rats.
Results: Compared with the normal group,the weight of rats in depression emotion model group lessened significantly(P<0.01), the crossing score,rearing score and total score of open field test all decreased obviously(P<0.01) and the sucrose intake of preference test decreased obviously(P<0.01).Meanwhile, the rats showed listlessness,dull in eyes and insensitive to surrounding stimulation.On the other hand,compared with the depression emotion model group,the weight of rats in Shuyu capsule and fluoxetine treatment groups increased significantly(P<0.05), the open field scores all increased remarkably(P<0.01),and the sucrose intake of preference test increased obviously(P<0.01),and there was no statistical differences in the two treatment groups(P>0.05).IF demonstrated that there was no noticeable differences in location of 5-HT_(3B)R infrontal cortex, parietal cortex, hippocampus and hypothalamus of rats in four groups.Compared with the normal group,the numerical value of MFI of 5-HT_(3B)R in depression emotion model group increased markedly (P<0.05 or P<0.01)in CA1、CA3 of hippocampus and in VMH, there maybe a elevated possibility of 5-HT_(3B)R in frontal cortex and parietal cortex. Compared with the depression emotion model group, the numerical value of MFI of 5-HT_(3B)R in Shuyu capsule and fluoxetine treatment groups decreased markedly (P<0.05)in CA1 of hippocampus and in VMH, there was no statistical differences in the two treatment groups(P>0.05), and there maybe a reducing possibility of 5-HT_(3B)R in frontal cortex and parietal cortex.
Conclusion: The model rats with depression emotion can be prepared successfully by using chronicity mild stimulus(CMS),and they can be evaluated effectively by sucrose preference test,open field test and macro-behavior observation.The high expressions of the5-HT_(3B)R protein in frontal cortex, parietal cortex, CA1、CA3 of hippocampus and in VMH may have close relationship with depression emotion,and probably is one of the centre pathogenesis of depression emotion.The Shuyu capsule can correct the high expression of 5-HT_(3B)R protein of model rats in above brain regions, which may be one of the mechanism to treat depression emotion.
方法:筛选大鼠进入实验,采用慢性温和应激法(CMS)复制抑郁情绪大鼠模型,以糖水偏好实验、旷场试验和宏观行为表现评价模型,以西药氟西汀为阳性药,采用免疫荧光法检测正常对照组、抑郁情绪模型组、舒郁胶囊给药组和氟西汀西药给药组大鼠额叶皮质、顶叶皮质、海马和下丘脑中5-HT_(3B)R的定位分布,并定量检测海马与下丘脑中5-HT_(3B)R的表达。
结果:与正常组大鼠相比,模型组大鼠体重显著减轻(P<0.01),旷场实验水平得分、垂直得分、旷场实验总分均显著减少(P<0.01),糖水偏好实验糖水摄入量显著减少(P<0.01),大鼠表现出精神萎靡,眼神呆滞,对外界刺激不敏感的状态;而造模并给予舒郁胶囊和氟西汀的大鼠较模型组大鼠体重增长显著(P<0.05),旷场实验三项得分均显著增加(P<0.01),糖水偏好实验中饮糖水量显著增加(P<0.01),但两组之间都没有显著性差异(P>0.05)。免疫荧光结果显示,四组大鼠额叶皮质、顶叶皮质、海马、下丘脑中5-HT_(3B)R的定位分布无显著性差异。与正常组大鼠相比,模型组大鼠海马CA1、CA3与下丘脑VMH区5-HT_(3B)R平均荧光强度(MFI)显著升高(P<0.05或P<0.01),额叶皮质、顶叶皮质5-HT_(3B)R有升高的可能。造模并给予舒郁胶囊和氟西汀治疗的大鼠与模型组相比,海马CA1、CA3与下丘脑VMH区5-HT_(3B)R平均荧光强度(MFI)显著降低(P<0.01),两组间没有显著性差异(P>0.05),额叶皮质、顶叶皮质5-HT_(3B)R有降低的可能。
结论:采用慢性温和应激法可以成功制备抑郁情绪大鼠模型,糖水偏好实验、旷场试验结合宏观行为药理学可有效评价模型。大鼠额叶皮质、顶叶皮质、海马CA1、CA3、下丘脑VMH区5-HT_(3B)R蛋白表达升高可能与抑郁情绪关系密切,可能是抑郁情绪发病的中枢机制之一;中药舒郁胶囊可以有效纠正模型大鼠上述脑区5-HT_(3B)R蛋白表达异常升高的状态,可能是该药治疗抑郁情绪的机制之一。
Objective:Our aim is to detect the relationship between protein location & expression levels of 5-HT_(3B)R in correlated region offrontal cortex , parietal cortex ,hippocampus & hypothalamus of depression emotion model rats, which gives a preliminary discussion on the pathogenesis of depression emotion,as well as studies the effects of Shuyu capsule.
Methods:After being chosen,depression emotion model rats were prepared by using chronicity mild stimulus(CMS)method.And then the rats were evaluated by sucrose preference test,open field test and macro-behavior observation.We used fluoxetine as masculine medicine, detected the 5-HT_(3B)R protein location in parietal cortex, frontal cortex, hippocampus and hypothalamus of rats in the groups including the normal group, depression emotion model group,and the two treatment groups by using immunofluorescence(IF), and detected the mean fluorescence intensity (MFI) in CA1、CA3 of hippocampus and in ventromedial hypothalamic area(VMH)of rats.
Results: Compared with the normal group,the weight of rats in depression emotion model group lessened significantly(P<0.01), the crossing score,rearing score and total score of open field test all decreased obviously(P<0.01) and the sucrose intake of preference test decreased obviously(P<0.01).Meanwhile, the rats showed listlessness,dull in eyes and insensitive to surrounding stimulation.On the other hand,compared with the depression emotion model group,the weight of rats in Shuyu capsule and fluoxetine treatment groups increased significantly(P<0.05), the open field scores all increased remarkably(P<0.01),and the sucrose intake of preference test increased obviously(P<0.01),and there was no statistical differences in the two treatment groups(P>0.05).IF demonstrated that there was no noticeable differences in location of 5-HT_(3B)R infrontal cortex, parietal cortex, hippocampus and hypothalamus of rats in four groups.Compared with the normal group,the numerical value of MFI of 5-HT_(3B)R in depression emotion model group increased markedly (P<0.05 or P<0.01)in CA1、CA3 of hippocampus and in VMH, there maybe a elevated possibility of 5-HT_(3B)R in frontal cortex and parietal cortex. Compared with the depression emotion model group, the numerical value of MFI of 5-HT_(3B)R in Shuyu capsule and fluoxetine treatment groups decreased markedly (P<0.05)in CA1 of hippocampus and in VMH, there was no statistical differences in the two treatment groups(P>0.05), and there maybe a reducing possibility of 5-HT_(3B)R in frontal cortex and parietal cortex.
Conclusion: The model rats with depression emotion can be prepared successfully by using chronicity mild stimulus(CMS),and they can be evaluated effectively by sucrose preference test,open field test and macro-behavior observation.The high expressions of the5-HT_(3B)R protein in frontal cortex, parietal cortex, CA1、CA3 of hippocampus and in VMH may have close relationship with depression emotion,and probably is one of the centre pathogenesis of depression emotion.The Shuyu capsule can correct the high expression of 5-HT_(3B)R protein of model rats in above brain regions, which may be one of the mechanism to treat depression emotion.
引文
[1]包祖晓,田青,陈宝君等.抑郁情绪伴随的常见症状中医用药规律分析[J].中医药学报,2010,38(5):7-9.
[2]龚绍麟.抑郁症[M].北京:人民卫生出版社,2003:1-3.
[3]江开达.抑郁障碍防治指南[M].北京:北京大学医学出版社,2007.
[4]金益强.中医肝脏象现代研究与临床.北京:人民卫生出版社,2000:104-105.
[5]车桂燕,周东丰,阮燕,等.肝郁气滞证病人尿MHPG-SO4测定及意义分析.黑龙江中医药,1989,(5):45.
[6]金益强,朱崇学,刘爱平,等.中医肝病五类证候血浆去甲肾上腺素和肾上腺素含量及诊断意义.湖南医科大学学报,1997,22(1):29-31.
[7]冯辉.抑郁症病机及临证治疗思路[J].天津中医药,2006,23(5):383-385.
[8]江开达.抑郁症的诊断与治疗[J].医学与哲学,2010,31(2):12-14.
[9]龙子江,宋建国.精神药理学[M].安徽:安徽大学出版社,2004:76-85.
[10]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[11]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[12]Can Yang,Gahua Wang, HuilingWang etal.Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress[J].Behavioural Brain Research,2009,205:518-524.
[13]Janne Gronli,Robert Murison,Eldbjorg Fiske etal.Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions[J].Physiology & Behavior,2005,84:571-577.
[14]Qing-Qiu Mao,Siu-Po Ip,Kam-Ming Ko etal. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry,2009,33:1211–1216.
[15]徐叔云,卞如濂,陈修.药理实验方法学[M].北京:人民卫生出版社,2002:202-203.
[16]刘晓伟,张红梅,曲宏达,等.“怒伤气”大鼠行为观察与检测[J].江苏中医药,2005,3(26):53.
[17]George P,Charles W.大鼠脑立体定位图谱[M].北京:人民卫生出版社,2005,7: Figure25-40.
[18]谭卫峰,陈丽阳.高压修复与微波修复在免疫组织化学中的应用比较[J].现代中西医结合杂志,2008,17(28):4449-4450.
[60]王玮文,邵枫,刘美等.早期应激对抑郁相关行为及神经内分泌反应的长期影响[J].心理科学进展,2006,14(6):907-911.
[19]乔明琦,张惠云.中医情志学[M].北京:人民卫生出版社,2009,2:138-329.
[20]徐兴国.《内经》情志病特点及治疗浅析[J].四川中医,1996,14(2):16.
[21]吕直.解读中医情志疾病研究[J].中医药学刊,2004,9(22):1601-1602.
[22]张保华.略谈七情病症的常用治法[J].安徽中医学院学报,1997,4(16):43.
[23]金曦,金冬.论情志病发病机理[J].中国中医基础医学杂志,2001,7(7):20-21.
[24]唐国斌,许永贵.情志致病与肾阳虚之间的关系[J].长春中医学院学报,2003,19(1):9.
[25]黄跃东,李泊,赵俊芳.中医情志的发生机制当议[J].福建中医学院学报,2004,14(4):43-45.
[26]陈煜辉.中医情志学科建设及情志病证临床防治框架构建探讨[J].广州中医药大学,博士论文,2005.
[27]李克光.金医要略讲义[M].上海:上海科学技术出版社,1985,10:250.
[28]朱震亨.丹溪治法心要[M].济南:山东科学技术出版社,1985,16.
[29]虞拎.医学正传[M].北京:人民卫生出版社,1965,4:85.
[30]侯彩兰,贾福军,陈佐明等.重性抑郁症患者脑脊液中P物质、神经肽Y、5-羟色胺及去甲肾上腺素含量的研究[J].中华精神科杂志,2005,38(4):198-201.
[31]Jay TM,Rocher C,Hotte M etal.Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress :importance for psychiatric diseases[J].Neurotox Res,2004, 6(3):233-244.
[32]Dailly E,ChenuF,Renard CE etal.Dopamine,depression and antidepressants[J].Fundam ClinPharmacol,2004,18(6):601-607.
[33]Leggio GM,Micale V,Drago F.Increased sensitivity to antidepressants of D3 dopamine receptor deficient mice in the forced swim test(FST)[J].Eur Neuropsychopharmacol,2008,18(4):271-277.
[34]王一牛,罗跃嘉.前额叶皮质损伤患者的情绪异常[J].心理科学进展,2004,12(2):161- 167.
[35]Davidson R J.Anxiety and affective style: role of prefrontal cortex and amygdale[J]. Biological Psychiatry,2002,51(1):68-80.
[36]郑金龙,吴永明,舒斯云.人脑顶叶在空间记忆认知功能中的作用[J].天津医药,2008,36(2):81-83.
[37]Rolls ET.The fuctions of the orbit frontal cotex[J].Brain Cogn,2004,55:11-29.
[38]Bishop S,Duncan J,Brett M etal.Prefrontal cortical function and anxiety:controlling attention to threatrelated stimuli[J].Na Neurosci,2004,7:184-188.
[39]Miller EK.The prefrontal cotex and cognitive control[J].Nat Rev Neurosci,2000,1:59-65.
[40]梁邦领,薛爱芹,王海蓉.海马结构的解剖学研究进展[J].菏泽医学专科学校学报,2006,18(3):73-75.
[41]Dam AM.The density of neurous in the human hippocampus[J].Neuropathology and Applied Neurobiology,1979,5:249.
[42]Frodl T,Meisenzahl EM,Zetzsche T,et al.Hippocampal changes in patients with a first episode of major depression[J].Am J Psychiatry,2002,l59(7):1112-8.
[43]Kempermann G,Kronenberg G.Deperssed new neurons-adult hippocampal neuorgenesis and a cellular plasticity hypothesis of major depression[J].Bid Psychiatry,2003,54(5):499-503.
[44]Lucassen PJ,MunerMB,HolsboerF,et al.Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure[J].Am J Pathol,2001,158(2):453-68.
[45]Duman RS,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disordep3[J].Biol Psychiatry,2000,48:732-739.
[46]刘文燮.试析下丘脑[J].生物学通报,2009,44(7):17-19.
[47]Funahashi H,Takenoya F,Guan JL,et al.Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding[J].R Anatomical Science International,2003,78(3):123-138.
[48]Debree FM,Vander AAM,Nijenhuis M,et al.The hormone domain of thevasopr- essin prohormone is required for the correct prohormone trafficking through the secretory pathway[J].Journal of Neuroendocrinology,2003,15(12):1156-1163.
[49]Amcheslavskii VG,Bragina NM,Dobrokhotova TA,et al.Water electrolyte disorders in the postoperative clinical picture of basaldiencephalitic tumors[J].Zhurnal Voprosy Neirokhirurgii Imeni N-N-Burdenko,2002,43(2):39-42.
[50]吴斌.大鼠杏仁核-下丘脑神经通路研究[J].自然科学杂志,2000,201(1):75-77.
[51]张宁霞,童瑶.应激对海马结构和功能影响的研究进展[J].中华国际医学杂志, 2002,2(6):542-544.
[52]姚泰.生理学[M].北京:人民卫生出版社,2005,6:356-358.
[53]朝明飞,高东,孙学礼.应激抑郁动物模型的建立与评价[J].华西医学,2008,23(4):901-902.
[54]Solomon DA,Keller MB,Leon AC etal.Multiple recurrences of major depressive disorder[J].Am J Psychiatry,2000,157(2):229-233.
[55]Katz RJ,Hersch S.Amitriptyline and scopol amine in animal model of depression[J]. Neurosci Biobehav Rev,1981,5(3):265-271.
[56]Willner P,Towel A,Sampson D,etal.Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic anti-depressant[J].Psychopharmacology,1987,93(3):358-364.
[57]Vry LD,Schreiber R.The chronic mild stress depression model:future developments froma drug discoveuperspective[J].Psychopharmcology,1997,134(3):349-350.
[58]Porsoh RD. Animal models of depression:Utility for tranagenic research[J].Rev Neurosci,2000,11(1):53-58.
[59]Harro J. Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry[J]. Brain Res, 2001; 899(1-2):227-239.
[61]Forbes NF,Caroline A,Keith M,etal.Chronic mild stress and sucrose consumption:validity as a model of depression[J].Physiology & Behavior,1996, 60(60):1481-1484.
[62]郁缪宇.抑郁障碍生化与慢性应激动物模型的建立及行为学评价[J].广西医科大学学报,2008,25(4):596-598.
[63]方肇勤.辨证论治实验方法学—实验小鼠诊法与辨证[M].上海:上海科学技术出版社,2006:155-157.
[64]Kessel B.Premenstrual syndrome. Advances in diagnosis and treatment[J].Obstet Gynecol Clin North Am,2000,27:(6)25-39.
[65]郑金炽,林贤浩.慢性应激动物模型研究进展[J]四川精神卫生,2010,23(2):附3-5.
[66]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[67]Jensen,A.A, Frolund B, Liljefors T etal.Neuronal nicotinic acetylcholine receptors:structural revelations,target identifications and therapeutic inspirations[J].J.Med.Chem,2005, 48(15):4705–4745.
[68]Whiting,P.J.GABA-A receptor subtypes in the brain:a paradigm for CNS drug discovery[J].Drug Discov.Today,2003,8(10):445–450.
[69]Lynch,J.W.Molecular structure and function of the glycine receptor chloride channel[J].Physiol.Rev,2004,84(4):1051–1095.
[70]Davies PA,PistisM,HannaMC et a1.The 5-HT3B subunit is a major determinant of seroton in receptor function[J].Nature,1999,397(6717):359-363.
[71]Tremblay P.B,Kaiser R,Sezer O etal.Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients[J].J Clin Oncol,2003,21(11):2147–2155.
[72]BOESS GF,BEROUKHI M R,MARTIN I L.Ultrastructure of the 5-hydroxy tryptamine 3 receptor[J].Neuroehem,1995,64:1401-1405.
[73]Lummis S C R.The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gating[J].Bioehem Soe Trans,2004,32:535-539.
[74]隋红,陆杰. 5-HT3R的分型、调节剂及拮抗剂的研究应用[J]. Foreign Medical Sciences·Section of Pathophysiology and Clinical Medicine,2005,25(2):179-182.
[75]Miyake A,Mochizuki S,Takemoto Y etal.Molecular cloning of human 5-hydroxytryptamine 3 receptor:heterogeneity in distribution and function among species[J].Mol Pharmacol,1995,48:407-416.
[76]Niesler B,Frank B,Kapeller J etal. Cloning,physical mapping and expression analysis of the human 5-HT3 seroton in receptor-like genes HTR3C,HTR3D and HTR3E[J].Gene,2003,310:101–111.
[77]Adrienne E.Dubin,Rene Huvar,Michael R.D’Andrea etal. The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit[J]. The American Society for Biochemistry and Molecular Biology,Inc,1999,274(43):30799-30810.
[78]Frank B,Niesler B,Nothen MM etal.Investigation of the human seroton in receptor gene HTR3B in bipolar affective and schizophrenic patients[J].Am J Med Genet B Neuropsychiatr Genet,2004,131B(1)1–5.
[79]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[80]Marisela Morales,Shwun-DeWang.Differential Composition of 5-Hydroxytryptamine 3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System[J]. The Journal of Neuroscience,2002, 22(15):6732–6741.
[81]Edith Doucet,Alban Latremoliere,Michele Darmon etal.Immunolabelling of the 5-HT3B receptor subunit in the central and peripheral nervous systems in rodents[J]. European Journal of Neuroscience,2007,26:355-366.
[82]Monk S.A.,Desai K.,Brady C.A. etal. Generation of a selective 5-HT3B subunit-recognising polyclonal antibody;identification of immunoreactive cells in rat hippocampus[J].Neuropharmacology,2001, 41:1013-1016.
[83]Reeves,D.C.,Lummis,S.C. Detection of human and rodent 5-HT3B receptor subunits by anti-peptide polyclonal antibodies[J].BMC Neurosci,2006,29(7):27.
[84]Gehlert D.R.,Gackenheimer S.L.,Wong D.T. etal.Localization of 5-HT3 receptors in the rat brain using[3H]LY278584[J]. Brain Res,1991,553:149e154.
[85]Laporte A.M.,Koscielniak T.,Ponchant M. etal.Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I] iodo-zacopride and [3H] zacoprideasradio-ligands[J].Synapse,1992, 10:271-281.
[86]Steward L.J.,West K.E.,Kilpatrick G.J. etal. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand[3H]meta-chlorophenylbiguanide[J]. Eur.J.Pharmacol,1993, 243:13-18.
[87]Parker R.M.C.,Barnes J.M.,Ge J. etal.Auto-radiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain[J]. J.Neurol.Sci,1996, 144:119-127.
[88]Mladen Vassilev Tzvetkov,Cornelia Meineke,Elke Oetjen etal. Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386:52-62.
[89]乔明琦.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16(3):23-26.
[90]李慧,林凌云,张印南,等.抑郁模型大鼠脑内色氨酸及5-羟色胺的改变[J].中华神经科杂志,2006;39(4):233-235.
[91]Berton O , EJ Nestler. New approaches to antidepressant drug discovery : beyond monoamines[J]. Nat Rev Neurosci, 2006;7(2):137-151.
[92]Pittenger C , RS Duman. Stress , depression, and neuroplasticity : a convergence of mechanisms[J]. Neuropsychopharmacology, 2008;33(1): 88-109.
[93]Bagdy E,Solyom S,Harsing LG.Feedback stimulation of somatodendritic serotonin release:a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat[J].Brain Res Bull,1998,45:203-208.
[94]Miquel MC,Emerit MB,Nosjean A etal.Differential subcellular localization of the 5-HT3-As receptor sub-unit in the rat central nervous system[J].Eur J Neurosci,2002,15:449-457.
[95]和友,金国章.多巴胺D3受体(D3R)的神经科学新进展[J].生命科学,2005,17(2):170-175.
[96]Imperato A,Puglisi-Allegra S,Zocchi A etal.Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam[J].Eur J Pharmacol,1990,175:211-214.
[97]De Deurwaerdere P,Moison D,Navailles S etal.Regionally and functionally distinct serotonin-3 receptors control in vivo dopamine outflow in the rat nucleus accumbens[J].J Neurochem,2005.94:140-149.
[98]Kankaanpaa A,Meririnne E,Seppala T. 5-HT3 receptor antagonist MDL72222 attenuates cocaine- and mazindol-, but not methylphenidate induced neurochemical and behavioural effects in the rat[ J].Psychopharmacology,2002,159:341-350.
[99]Porras G,De Deurwaerdere P, Moison D etal.Conditional involvement of striatal serotonin 3 receptors in the control of in vivo dopamine outflow in the rat striatum[J].Eur J Neurosci,2003,17:771-781.
[100]Tsang S Y,Carl P,Xue H.Development of effective therapeutics targeting the GABAA receptor:naturally occurring alternative [J].Curr Pharmaceut Design,2004,10(9);1035-1045.
[101]Stell BM,Brickley SG,Tang CY,et al.Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors[J].Proc Natl Acad Sci USA,2003,100(24):14439-14444.
[102]Koyama S,Matsumoto N,Kubo C etal.Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons[J].J Physiol(Lond),2000,529:373-383.
[103]Puig MV,Santana N,Celada P etal.In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors[J].Cereb Cortex,2004,14:1365-1375.
[104]McMahon LL,Kauer JA.Hippocampal interneurons are excited via serotonin-gated ion channels[J].J Neurophysiol,1997,78:2493-2502.
[105]Aina Y,Susman JL.Understanding comorbidity with depression and anxiety disorders[J].J Am Osteopath Assoc,2006,106:S9-S14.
[106]Cameron OG.Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions[J].Essent Psychopharmacol,2006,7:24-34.
[107]Dolnak DR.Treating patients for comorbid depression, anxiety disorders, and somatic illnesses[J].J Am Osteopath Assoc,2006,106:S1-S8.
[108]Nutt DJ,Stein DJ.Understanding the neurobiology of comorbidity in anxiety disorders[J].CNS Spectr,2006,11:13-20.
[109]Varea E,Blasco-Ibanez JM,Gomez-Climent MA et al.Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex[J].Neuropsychopharmacology,2007,32:803-812.
[110]Mitchell EA,Pratt JA.Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat[J].Brain Res,1991,538:289-294.
[111]Becker C,Zeau B,Rivat C etal.Repeated social defeat-induced depression-like behavioural and biological alterations in rats: involvement of cholecystokinin[J].Mol Psychiatr,2008,13:1079-1092.
[112]Ramamoorthy Rajkumar,Radhakrishnan Mahesh.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target[J].Journal of Psychopharmacology,2010,24(4):455-469.
[1]Tierney, A. J.Structure and function of invertebrate 5-HT receptors: a review[J]. Comp Biochem Physiol A Mol Integr Physiol,2001,128(4):791-804.
[2]Cynthia L.Bethea,Nick Z. Lu,Chrisana Gundlah et al.Diverse Actions of Ovarian Steroids in the Serotonin Neural System[J].Frontiers in Neuroendocrinology,2002,23:41-100.
[3]Jacobs BL,Azmitia EC.Structure and function of the brain serotonin system[J].Physiol Rev,1992,72:165-231.
[4]Wesley K. Kroeze,Kurt Kristiansen,Bryan L. Roth.Molecular Biology of Serotonin Receptors-Structure and Function at the Molecular Level[J].Current Topics in Medicinal Chemistry,2002,2:507-528.
[5]Mladen Vassilev Tzvetkov ,Cornelia Meineke,Elke Oetjen etal.Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386(1-2)52–62.
[6]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[7]Jensen,A.A, Frolund B, Liljefors T etal.Neuronal nicotinic acetylcholine receptors:structural revelations,target identifications and therapeutic inspirations[J].J.Med.Chem,2005, 48(15):4705–4745.
[8]Whiting,P.J.GABA-A receptor subtypes in the brain:a paradigm for CNS drug discovery[J].Drug Discov.Today,2003,8(10):445–450.
[9]Lynch,J.W.Molecular structure and function of the glycine receptor chloride channel[J].Physiol.Rev,2004,84(4):1051–1095.
[10]Chameau,P.andvanHooft,J.A.Serotonin 5-HT3 receptors in the central nervous system[J].Cell Tissue Res,2006,326:573–581.
[11]Barnes N.M,Sharp T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083–1152.
[12]Hornby P.J.Central neurocircuitry associated with emesis[J].Am.J.Med,2001,111(8):106S–112S.
[13]Thompson A.J,Lummis S.C.The 5-HT3 receptor as a therapeutic target[J].Expert Opin.Ther.Targets,2007,11(4):527–540.
[14]BOESS GF,BEROUKHI M R,MARTIN I L.Ultrastructure of the 5-hydroxy tryptamine 3 receptor[J].Neuroehem,1995,64:1401-1405.
[15]Lummis S C R.The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gating[J].Bioehem Soe Trans,2004,32:535-539.
[16]隋红,陆杰. 5-HT3受体的分型、调节剂及拮抗剂的研究应用[J]. Foreign Medical Sciences·Section of Pathophysiology and Clinical Medicine,2005,25(2):179-182.
[17]Dubin AE, Huvar R, D’Andrea MR,et al.The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit[J].J Biol Chem,1999,274(43):30799-30810.
[18]Miyake A,Mochizuki S,Takemoto Y etal.Molecular cloning of human 5-hydroxytryptamine 3 receptor:heterogeneity in distribution and function among species[J].Mol Pharmacol,1995,48:407-416.
[19]Niesler B,Frank B,Kapeller J etal. Cloning,physical mapping and expression analysis of the human 5-HT3 seroton in receptor-like genes HTR3C,HTR3D and HTR3E[J].Gene,2003,310:101–111.
[20]Karnovsky,A.M. etal.A cluster of novel serotonin receptor 3-like genes on human chromosome 3[J].Gene,2003,319:137–148.
[21]Maricq AV,Petemon AS,Brake AJ eta1.Primary structure and functional expression of the 5HT3 receptor,a serotonin-gated ion channel[J].Science,1991,254(5030):432-437.
[22]MICQ A V, PETERSON A S,BRAKE A J eta1.Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel[J].Science,1991, 254:432-437.
[23]Davies PA,PistisM,HannaMC et a1.The 5-HT3B subunit is a major determinant of seroton in receptor function[J].Nature,1999,397(6717):359-363.
[24]Adrienne E.Dubin,Rene Huvar,Michael R.D’Andrea etal. The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a5-HT3B Receptor Subunit[J]. The American Society for Biochemistry and Molecular Biology,Inc,1999,274(43):30799-30810.
[25]Frank B,Niesler B,Nothen MM etal.Investigation of the human seroton in receptor gene HTR3B in bipolar affective and schizophrenic patients[J].Am J Med Genet B Neuropsychiatr Genet,2004,131B(1)1–5.
[26]Tremblay P.B,Kaiser R,Sezer O etal.Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients[J].J Clin Oncol,2003,21(11):2147–2155.
[27]Reeves DC,Lummis SC.The molecular basis of the structure and function of the 5-HT3 receptor:a model ligand-gated ion channel[J].Mol Membr Biol,2002,19:11–26.
[28]BeateNiesler,JuttaWalstab,SandraCombrink.Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D,and 5-HT3E[J]. Mol Pharmacol,2007,72(1):8–17.
[29]Sterling N.Sudweeks,,Johannes A.van Hooft,Jerrel L. Yakel.Serotonin 5-HT3 receptors in rat CA1 hippocampal interneurons: functional and molecular characterization[J]. The Physiological Society,2002,544(3):715-726.
[30]Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting[J].Br J Anaesth.,1992,69(7 ):60S-62S.
[31] PiercePA,xieGx,LevineJD etal.5-Hydroxytryptamine receptor subtype messenger RNAs in rat periplleral sensory and sympathetic ganglia:a polymerase chain reaetion study[J].Neuroseienee,1996,70:553-559.
[32]高纯颖,童晓青,徐峰. 5-HT3受体拮抗剂抑制化疗致吐的研究进展[J].沈阳药科大学学报,2007,24(4):254-258.
[33]Marisela Morales,Shwun-DeWang.Differential Composition of 5-Hydroxytryptamine 3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System[J]. The Journal of Neuroscience,2002, 22(15):6732–6741.
[34]LaPorteAM,FattaceiniCM.,LombardMC etal.Effeets of dorsal rhizotomy and selective lesion of serotonergiec and noradrenergic systems on 5-HT1A,5-HT1B and 5-HT3,receptors in the rats sprinal cord[J].J Neural Transm,1994,100:207-223.
[35]Kidd EJ,Laporte AM,Langloisx etal.5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and minals[J].Brain Res,1992,612:289-298.
[36]Todorovie S,Anderson EG.Serotonin Preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activatings 5-HT1A receptors[J].Brain Res,1992,585:212-218.
[37]Riehardson BP,Engle G,Donatseh P etal.Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.Nature,1985,316:126~131.
[38]Sakurai-Yamashita Y,Yamashita K,Kaibara M etal. Differential distribution of 5-hydroxytryptamine3 receptor in the colon between human and guinea pig[J].Chin J Physiol,1999,42(3):195-198.
[39]Glatzle J,Sternini C,Robin C etal. Expression of 5-HT3 receptors in the rat gastrointestinal tract[J].Gastroenterology,2002,123(1):217-226.
[40]Claeysen S,Sebben M,Becamel C etal. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain[J].Mol Pharmacol,1999,55(5):910-920.
[41]N.Chetty,R.Chess-Williams. Demonstration of 5-HT3 receptor function and expression in the mouse bladder[J].Naunyn-Schmiedeberg’s Arch Pharmacol,2007,375:359-368.
[42]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[43]Edith Doucet,Alban Latremoliere,Michele Darmon etal.Immunolabelling of the 5-HT3B receptor subunit in the central and peripheral nervous systems in rodents[J]. European Journal of Neuroscience,2007,26:355-366.
[44]Monk S.A.,Desai K.,Brady C.A. etal. Generation of a selective 5-HT3B subunit-recognising polyclonal antibody;identification of immunoreactive cells in rat hippocampus[J].Neuropharmacology,2001, 41:1013-1016.
[45]Reeves,D.C.,Lummis,S.C. Detection of human and rodent 5-HT3B receptor subunits by anti-peptide polyclonal antibodies[J].BMC Neurosci,2006,29(7):27.
[46]Gehlert D.R.,Gackenheimer S.L.,Wong D.T. etal.Localization of 5-HT3 receptors in the rat brain using[3H]LY278584[J]. Brain Res,1991,553:149e154.
[47]Laporte A.M.,Koscielniak T.,Ponchant M. etal.Quantitative autoradiographic mapping of5-HT3 receptors in the rat CNS using [125I] iodo-zacopride and [3H] zacoprideasradio-ligands[J].Synapse,1992, 10:271-281.
[48]Steward L.J.,West K.E.,Kilpatrick G.J. etal. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand[3H]meta-chlorophenylbiguanide[J]. Eur.J.Pharmacol,1993, 243:13-18.
[49]Parker R.M.C.,Barnes J.M.,Ge J. etal.Auto-radiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain[J]. J.Neurol.Sci,1996, 144:119-127.
[50]Mladen Vassilev Tzvetkov,Cornelia Meineke,Elke Oetjen etal. Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386:52-62.
[51]CAPPELLI A,GALLELLI A,BRAILE C eta1.Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure. Effects of the quaternization of the basic nitrogen on the interaction with 5-HT3 receptor[J].Bioorg Med Chem,2002,10:2681-2691.
[52]乔明琦.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16(3):23-26.
[53]李慧,林凌云,张印南,等.抑郁模型大鼠脑内色氨酸及5-羟色胺的改变[J].中华神经科杂志,2006;39(4):233-235.
[54]Berton O , EJ Nestler. New approaches to antidepressant drug discovery : beyond monoamines[J]. Nat Rev Neurosci, 2006;7(2):137-151.
[55]Pittenger C , RS Duman. Stress , depression, and neuroplasticity : a convergence of mechanisms[J]. Neuropsychopharmacology, 2008;33(1): 88-109.
[56]Bagdy E,Solyom S,Harsing LG.Feedback stimulation of somatodendritic serotonin release:a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat[J].Brain Res Bull,1998,45:203-208.
[57]Miquel MC,Emerit MB,Nosjean A etal.Differential subcellular localization of the 5-HT3-As receptor sub-unit in the rat central nervous system[J].Eur J Neurosci,2002,15:449-457.
[58]和友,金国章.多巴胺D3受体(D3R)的神经科学新进展[J].生命科学,2005,17(2):170-175.
[59]Imperato A,Puglisi-Allegra S,Zocchi A etal.Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam[J].Eur J Pharmacol,1990,175:211-214.
[60]De Deurwaerdere P,Moison D,Navailles S etal.Regionally and functionally distinct serotonin-3 receptors control in vivo dopamine outflow in the rat nucleus accumbens[J].J Neurochem,2005.94:140-149.
[61]Kankaanpaa A,Meririnne E,Seppala T. 5-HT3 receptor antagonist MDL72222 attenuates cocaine- and mazindol-, but not methylphenidate induced neurochemical and behavioural effects in the rat[ J].Psychopharmacology,2002,159:341-350.
[62]Porras G,De Deurwaerdere P, Moison D etal.Conditional involvement of striatal serotonin 3 receptors in the control of in vivo dopamine outflow in the rat striatum[J].Eur J Neurosci,2003,17:771-781.
[63]Tsang S Y,Carl P,Xue H.Development of effective therapeutics targeting the GABAA receptor:naturally occurring alternative [J].Curr Pharmaceut Design,2004,10(9);1035-1045.
[64]Stell BM,Brickley SG,Tang CY,et al.Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors[J].Proc Natl Acad Sci USA,2003,100(24):14439-14444.
[65]Koyama S,Matsumoto N,Kubo C etal.Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons[J].J Physiol(Lond),2000,529:373-383.
[66]Puig MV,Santana N,Celada P etal.In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors[J].Cereb Cortex,2004,14:1365-1375.
[67]McMahon LL,Kauer JA.Hippocampal interneurons are excited via serotonin-gated ion channels[J].J Neurophysiol,1997,78:2493-2502.
[68]Aina Y,Susman JL.Understanding comorbidity with depression and anxiety disorders[J].J Am Osteopath Assoc,2006,106:S9-S14.
[69]Cameron OG.Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions[J].Essent Psychopharmacol,2006,7:24-34.
[70]Dolnak DR.Treating patients for comorbid depression, anxiety disorders, and somatic illnesses[J].J Am Osteopath Assoc,2006,106:S1-S8.
[71]Nutt DJ,Stein DJ.Understanding the neurobiology of comorbidity in anxiety disorders[J].CNS Spectr,2006,11:13-20.
[72]Varea E,Blasco-Ibanez JM,Gomez-Climent MA et al.Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex[J].Neuropsychopharmacology,2007,32:803-812.
[73]Mitchell EA,Pratt JA.Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat[J].Brain Res,1991,538:289-294.
[74]Becker C,Zeau B,Rivat C etal.Repeated social defeat-induced depression-like behavioural and biological alterations in rats: involvement of cholecystokinin[J].Mol Psychiatr,2008,13:1079-1092.
[75]Ramamoorthy Rajkumar,Radhakrishnan Mahesh.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target[J].Journal of Psychopharmacology,2010,24(4):455-469.
[2]龚绍麟.抑郁症[M].北京:人民卫生出版社,2003:1-3.
[3]江开达.抑郁障碍防治指南[M].北京:北京大学医学出版社,2007.
[4]金益强.中医肝脏象现代研究与临床.北京:人民卫生出版社,2000:104-105.
[5]车桂燕,周东丰,阮燕,等.肝郁气滞证病人尿MHPG-SO4测定及意义分析.黑龙江中医药,1989,(5):45.
[6]金益强,朱崇学,刘爱平,等.中医肝病五类证候血浆去甲肾上腺素和肾上腺素含量及诊断意义.湖南医科大学学报,1997,22(1):29-31.
[7]冯辉.抑郁症病机及临证治疗思路[J].天津中医药,2006,23(5):383-385.
[8]江开达.抑郁症的诊断与治疗[J].医学与哲学,2010,31(2):12-14.
[9]龙子江,宋建国.精神药理学[M].安徽:安徽大学出版社,2004:76-85.
[10]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[11]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[12]Can Yang,Gahua Wang, HuilingWang etal.Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress[J].Behavioural Brain Research,2009,205:518-524.
[13]Janne Gronli,Robert Murison,Eldbjorg Fiske etal.Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions[J].Physiology & Behavior,2005,84:571-577.
[14]Qing-Qiu Mao,Siu-Po Ip,Kam-Ming Ko etal. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry,2009,33:1211–1216.
[15]徐叔云,卞如濂,陈修.药理实验方法学[M].北京:人民卫生出版社,2002:202-203.
[16]刘晓伟,张红梅,曲宏达,等.“怒伤气”大鼠行为观察与检测[J].江苏中医药,2005,3(26):53.
[17]George P,Charles W.大鼠脑立体定位图谱[M].北京:人民卫生出版社,2005,7: Figure25-40.
[18]谭卫峰,陈丽阳.高压修复与微波修复在免疫组织化学中的应用比较[J].现代中西医结合杂志,2008,17(28):4449-4450.
[60]王玮文,邵枫,刘美等.早期应激对抑郁相关行为及神经内分泌反应的长期影响[J].心理科学进展,2006,14(6):907-911.
[19]乔明琦,张惠云.中医情志学[M].北京:人民卫生出版社,2009,2:138-329.
[20]徐兴国.《内经》情志病特点及治疗浅析[J].四川中医,1996,14(2):16.
[21]吕直.解读中医情志疾病研究[J].中医药学刊,2004,9(22):1601-1602.
[22]张保华.略谈七情病症的常用治法[J].安徽中医学院学报,1997,4(16):43.
[23]金曦,金冬.论情志病发病机理[J].中国中医基础医学杂志,2001,7(7):20-21.
[24]唐国斌,许永贵.情志致病与肾阳虚之间的关系[J].长春中医学院学报,2003,19(1):9.
[25]黄跃东,李泊,赵俊芳.中医情志的发生机制当议[J].福建中医学院学报,2004,14(4):43-45.
[26]陈煜辉.中医情志学科建设及情志病证临床防治框架构建探讨[J].广州中医药大学,博士论文,2005.
[27]李克光.金医要略讲义[M].上海:上海科学技术出版社,1985,10:250.
[28]朱震亨.丹溪治法心要[M].济南:山东科学技术出版社,1985,16.
[29]虞拎.医学正传[M].北京:人民卫生出版社,1965,4:85.
[30]侯彩兰,贾福军,陈佐明等.重性抑郁症患者脑脊液中P物质、神经肽Y、5-羟色胺及去甲肾上腺素含量的研究[J].中华精神科杂志,2005,38(4):198-201.
[31]Jay TM,Rocher C,Hotte M etal.Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress :importance for psychiatric diseases[J].Neurotox Res,2004, 6(3):233-244.
[32]Dailly E,ChenuF,Renard CE etal.Dopamine,depression and antidepressants[J].Fundam ClinPharmacol,2004,18(6):601-607.
[33]Leggio GM,Micale V,Drago F.Increased sensitivity to antidepressants of D3 dopamine receptor deficient mice in the forced swim test(FST)[J].Eur Neuropsychopharmacol,2008,18(4):271-277.
[34]王一牛,罗跃嘉.前额叶皮质损伤患者的情绪异常[J].心理科学进展,2004,12(2):161- 167.
[35]Davidson R J.Anxiety and affective style: role of prefrontal cortex and amygdale[J]. Biological Psychiatry,2002,51(1):68-80.
[36]郑金龙,吴永明,舒斯云.人脑顶叶在空间记忆认知功能中的作用[J].天津医药,2008,36(2):81-83.
[37]Rolls ET.The fuctions of the orbit frontal cotex[J].Brain Cogn,2004,55:11-29.
[38]Bishop S,Duncan J,Brett M etal.Prefrontal cortical function and anxiety:controlling attention to threatrelated stimuli[J].Na Neurosci,2004,7:184-188.
[39]Miller EK.The prefrontal cotex and cognitive control[J].Nat Rev Neurosci,2000,1:59-65.
[40]梁邦领,薛爱芹,王海蓉.海马结构的解剖学研究进展[J].菏泽医学专科学校学报,2006,18(3):73-75.
[41]Dam AM.The density of neurous in the human hippocampus[J].Neuropathology and Applied Neurobiology,1979,5:249.
[42]Frodl T,Meisenzahl EM,Zetzsche T,et al.Hippocampal changes in patients with a first episode of major depression[J].Am J Psychiatry,2002,l59(7):1112-8.
[43]Kempermann G,Kronenberg G.Deperssed new neurons-adult hippocampal neuorgenesis and a cellular plasticity hypothesis of major depression[J].Bid Psychiatry,2003,54(5):499-503.
[44]Lucassen PJ,MunerMB,HolsboerF,et al.Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure[J].Am J Pathol,2001,158(2):453-68.
[45]Duman RS,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disordep3[J].Biol Psychiatry,2000,48:732-739.
[46]刘文燮.试析下丘脑[J].生物学通报,2009,44(7):17-19.
[47]Funahashi H,Takenoya F,Guan JL,et al.Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding[J].R Anatomical Science International,2003,78(3):123-138.
[48]Debree FM,Vander AAM,Nijenhuis M,et al.The hormone domain of thevasopr- essin prohormone is required for the correct prohormone trafficking through the secretory pathway[J].Journal of Neuroendocrinology,2003,15(12):1156-1163.
[49]Amcheslavskii VG,Bragina NM,Dobrokhotova TA,et al.Water electrolyte disorders in the postoperative clinical picture of basaldiencephalitic tumors[J].Zhurnal Voprosy Neirokhirurgii Imeni N-N-Burdenko,2002,43(2):39-42.
[50]吴斌.大鼠杏仁核-下丘脑神经通路研究[J].自然科学杂志,2000,201(1):75-77.
[51]张宁霞,童瑶.应激对海马结构和功能影响的研究进展[J].中华国际医学杂志, 2002,2(6):542-544.
[52]姚泰.生理学[M].北京:人民卫生出版社,2005,6:356-358.
[53]朝明飞,高东,孙学礼.应激抑郁动物模型的建立与评价[J].华西医学,2008,23(4):901-902.
[54]Solomon DA,Keller MB,Leon AC etal.Multiple recurrences of major depressive disorder[J].Am J Psychiatry,2000,157(2):229-233.
[55]Katz RJ,Hersch S.Amitriptyline and scopol amine in animal model of depression[J]. Neurosci Biobehav Rev,1981,5(3):265-271.
[56]Willner P,Towel A,Sampson D,etal.Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic anti-depressant[J].Psychopharmacology,1987,93(3):358-364.
[57]Vry LD,Schreiber R.The chronic mild stress depression model:future developments froma drug discoveuperspective[J].Psychopharmcology,1997,134(3):349-350.
[58]Porsoh RD. Animal models of depression:Utility for tranagenic research[J].Rev Neurosci,2000,11(1):53-58.
[59]Harro J. Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry[J]. Brain Res, 2001; 899(1-2):227-239.
[61]Forbes NF,Caroline A,Keith M,etal.Chronic mild stress and sucrose consumption:validity as a model of depression[J].Physiology & Behavior,1996, 60(60):1481-1484.
[62]郁缪宇.抑郁障碍生化与慢性应激动物模型的建立及行为学评价[J].广西医科大学学报,2008,25(4):596-598.
[63]方肇勤.辨证论治实验方法学—实验小鼠诊法与辨证[M].上海:上海科学技术出版社,2006:155-157.
[64]Kessel B.Premenstrual syndrome. Advances in diagnosis and treatment[J].Obstet Gynecol Clin North Am,2000,27:(6)25-39.
[65]郑金炽,林贤浩.慢性应激动物模型研究进展[J]四川精神卫生,2010,23(2):附3-5.
[66]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[67]Jensen,A.A, Frolund B, Liljefors T etal.Neuronal nicotinic acetylcholine receptors:structural revelations,target identifications and therapeutic inspirations[J].J.Med.Chem,2005, 48(15):4705–4745.
[68]Whiting,P.J.GABA-A receptor subtypes in the brain:a paradigm for CNS drug discovery[J].Drug Discov.Today,2003,8(10):445–450.
[69]Lynch,J.W.Molecular structure and function of the glycine receptor chloride channel[J].Physiol.Rev,2004,84(4):1051–1095.
[70]Davies PA,PistisM,HannaMC et a1.The 5-HT3B subunit is a major determinant of seroton in receptor function[J].Nature,1999,397(6717):359-363.
[71]Tremblay P.B,Kaiser R,Sezer O etal.Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients[J].J Clin Oncol,2003,21(11):2147–2155.
[72]BOESS GF,BEROUKHI M R,MARTIN I L.Ultrastructure of the 5-hydroxy tryptamine 3 receptor[J].Neuroehem,1995,64:1401-1405.
[73]Lummis S C R.The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gating[J].Bioehem Soe Trans,2004,32:535-539.
[74]隋红,陆杰. 5-HT3R的分型、调节剂及拮抗剂的研究应用[J]. Foreign Medical Sciences·Section of Pathophysiology and Clinical Medicine,2005,25(2):179-182.
[75]Miyake A,Mochizuki S,Takemoto Y etal.Molecular cloning of human 5-hydroxytryptamine 3 receptor:heterogeneity in distribution and function among species[J].Mol Pharmacol,1995,48:407-416.
[76]Niesler B,Frank B,Kapeller J etal. Cloning,physical mapping and expression analysis of the human 5-HT3 seroton in receptor-like genes HTR3C,HTR3D and HTR3E[J].Gene,2003,310:101–111.
[77]Adrienne E.Dubin,Rene Huvar,Michael R.D’Andrea etal. The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit[J]. The American Society for Biochemistry and Molecular Biology,Inc,1999,274(43):30799-30810.
[78]Frank B,Niesler B,Nothen MM etal.Investigation of the human seroton in receptor gene HTR3B in bipolar affective and schizophrenic patients[J].Am J Med Genet B Neuropsychiatr Genet,2004,131B(1)1–5.
[79]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[80]Marisela Morales,Shwun-DeWang.Differential Composition of 5-Hydroxytryptamine 3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System[J]. The Journal of Neuroscience,2002, 22(15):6732–6741.
[81]Edith Doucet,Alban Latremoliere,Michele Darmon etal.Immunolabelling of the 5-HT3B receptor subunit in the central and peripheral nervous systems in rodents[J]. European Journal of Neuroscience,2007,26:355-366.
[82]Monk S.A.,Desai K.,Brady C.A. etal. Generation of a selective 5-HT3B subunit-recognising polyclonal antibody;identification of immunoreactive cells in rat hippocampus[J].Neuropharmacology,2001, 41:1013-1016.
[83]Reeves,D.C.,Lummis,S.C. Detection of human and rodent 5-HT3B receptor subunits by anti-peptide polyclonal antibodies[J].BMC Neurosci,2006,29(7):27.
[84]Gehlert D.R.,Gackenheimer S.L.,Wong D.T. etal.Localization of 5-HT3 receptors in the rat brain using[3H]LY278584[J]. Brain Res,1991,553:149e154.
[85]Laporte A.M.,Koscielniak T.,Ponchant M. etal.Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I] iodo-zacopride and [3H] zacoprideasradio-ligands[J].Synapse,1992, 10:271-281.
[86]Steward L.J.,West K.E.,Kilpatrick G.J. etal. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand[3H]meta-chlorophenylbiguanide[J]. Eur.J.Pharmacol,1993, 243:13-18.
[87]Parker R.M.C.,Barnes J.M.,Ge J. etal.Auto-radiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain[J]. J.Neurol.Sci,1996, 144:119-127.
[88]Mladen Vassilev Tzvetkov,Cornelia Meineke,Elke Oetjen etal. Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386:52-62.
[89]乔明琦.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16(3):23-26.
[90]李慧,林凌云,张印南,等.抑郁模型大鼠脑内色氨酸及5-羟色胺的改变[J].中华神经科杂志,2006;39(4):233-235.
[91]Berton O , EJ Nestler. New approaches to antidepressant drug discovery : beyond monoamines[J]. Nat Rev Neurosci, 2006;7(2):137-151.
[92]Pittenger C , RS Duman. Stress , depression, and neuroplasticity : a convergence of mechanisms[J]. Neuropsychopharmacology, 2008;33(1): 88-109.
[93]Bagdy E,Solyom S,Harsing LG.Feedback stimulation of somatodendritic serotonin release:a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat[J].Brain Res Bull,1998,45:203-208.
[94]Miquel MC,Emerit MB,Nosjean A etal.Differential subcellular localization of the 5-HT3-As receptor sub-unit in the rat central nervous system[J].Eur J Neurosci,2002,15:449-457.
[95]和友,金国章.多巴胺D3受体(D3R)的神经科学新进展[J].生命科学,2005,17(2):170-175.
[96]Imperato A,Puglisi-Allegra S,Zocchi A etal.Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam[J].Eur J Pharmacol,1990,175:211-214.
[97]De Deurwaerdere P,Moison D,Navailles S etal.Regionally and functionally distinct serotonin-3 receptors control in vivo dopamine outflow in the rat nucleus accumbens[J].J Neurochem,2005.94:140-149.
[98]Kankaanpaa A,Meririnne E,Seppala T. 5-HT3 receptor antagonist MDL72222 attenuates cocaine- and mazindol-, but not methylphenidate induced neurochemical and behavioural effects in the rat[ J].Psychopharmacology,2002,159:341-350.
[99]Porras G,De Deurwaerdere P, Moison D etal.Conditional involvement of striatal serotonin 3 receptors in the control of in vivo dopamine outflow in the rat striatum[J].Eur J Neurosci,2003,17:771-781.
[100]Tsang S Y,Carl P,Xue H.Development of effective therapeutics targeting the GABAA receptor:naturally occurring alternative [J].Curr Pharmaceut Design,2004,10(9);1035-1045.
[101]Stell BM,Brickley SG,Tang CY,et al.Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors[J].Proc Natl Acad Sci USA,2003,100(24):14439-14444.
[102]Koyama S,Matsumoto N,Kubo C etal.Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons[J].J Physiol(Lond),2000,529:373-383.
[103]Puig MV,Santana N,Celada P etal.In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors[J].Cereb Cortex,2004,14:1365-1375.
[104]McMahon LL,Kauer JA.Hippocampal interneurons are excited via serotonin-gated ion channels[J].J Neurophysiol,1997,78:2493-2502.
[105]Aina Y,Susman JL.Understanding comorbidity with depression and anxiety disorders[J].J Am Osteopath Assoc,2006,106:S9-S14.
[106]Cameron OG.Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions[J].Essent Psychopharmacol,2006,7:24-34.
[107]Dolnak DR.Treating patients for comorbid depression, anxiety disorders, and somatic illnesses[J].J Am Osteopath Assoc,2006,106:S1-S8.
[108]Nutt DJ,Stein DJ.Understanding the neurobiology of comorbidity in anxiety disorders[J].CNS Spectr,2006,11:13-20.
[109]Varea E,Blasco-Ibanez JM,Gomez-Climent MA et al.Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex[J].Neuropsychopharmacology,2007,32:803-812.
[110]Mitchell EA,Pratt JA.Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat[J].Brain Res,1991,538:289-294.
[111]Becker C,Zeau B,Rivat C etal.Repeated social defeat-induced depression-like behavioural and biological alterations in rats: involvement of cholecystokinin[J].Mol Psychiatr,2008,13:1079-1092.
[112]Ramamoorthy Rajkumar,Radhakrishnan Mahesh.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target[J].Journal of Psychopharmacology,2010,24(4):455-469.
[1]Tierney, A. J.Structure and function of invertebrate 5-HT receptors: a review[J]. Comp Biochem Physiol A Mol Integr Physiol,2001,128(4):791-804.
[2]Cynthia L.Bethea,Nick Z. Lu,Chrisana Gundlah et al.Diverse Actions of Ovarian Steroids in the Serotonin Neural System[J].Frontiers in Neuroendocrinology,2002,23:41-100.
[3]Jacobs BL,Azmitia EC.Structure and function of the brain serotonin system[J].Physiol Rev,1992,72:165-231.
[4]Wesley K. Kroeze,Kurt Kristiansen,Bryan L. Roth.Molecular Biology of Serotonin Receptors-Structure and Function at the Molecular Level[J].Current Topics in Medicinal Chemistry,2002,2:507-528.
[5]Mladen Vassilev Tzvetkov ,Cornelia Meineke,Elke Oetjen etal.Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386(1-2)52–62.
[6]Thompson,A.J.andLummis,S.C. 5-HT3 receptors[J].Curr.Pharm.Des,2006,12(28):3615–3630.
[7]Jensen,A.A, Frolund B, Liljefors T etal.Neuronal nicotinic acetylcholine receptors:structural revelations,target identifications and therapeutic inspirations[J].J.Med.Chem,2005, 48(15):4705–4745.
[8]Whiting,P.J.GABA-A receptor subtypes in the brain:a paradigm for CNS drug discovery[J].Drug Discov.Today,2003,8(10):445–450.
[9]Lynch,J.W.Molecular structure and function of the glycine receptor chloride channel[J].Physiol.Rev,2004,84(4):1051–1095.
[10]Chameau,P.andvanHooft,J.A.Serotonin 5-HT3 receptors in the central nervous system[J].Cell Tissue Res,2006,326:573–581.
[11]Barnes N.M,Sharp T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083–1152.
[12]Hornby P.J.Central neurocircuitry associated with emesis[J].Am.J.Med,2001,111(8):106S–112S.
[13]Thompson A.J,Lummis S.C.The 5-HT3 receptor as a therapeutic target[J].Expert Opin.Ther.Targets,2007,11(4):527–540.
[14]BOESS GF,BEROUKHI M R,MARTIN I L.Ultrastructure of the 5-hydroxy tryptamine 3 receptor[J].Neuroehem,1995,64:1401-1405.
[15]Lummis S C R.The transmembrane domain of the 5-HT3 receptor: its role in selectivity and gating[J].Bioehem Soe Trans,2004,32:535-539.
[16]隋红,陆杰. 5-HT3受体的分型、调节剂及拮抗剂的研究应用[J]. Foreign Medical Sciences·Section of Pathophysiology and Clinical Medicine,2005,25(2):179-182.
[17]Dubin AE, Huvar R, D’Andrea MR,et al.The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit[J].J Biol Chem,1999,274(43):30799-30810.
[18]Miyake A,Mochizuki S,Takemoto Y etal.Molecular cloning of human 5-hydroxytryptamine 3 receptor:heterogeneity in distribution and function among species[J].Mol Pharmacol,1995,48:407-416.
[19]Niesler B,Frank B,Kapeller J etal. Cloning,physical mapping and expression analysis of the human 5-HT3 seroton in receptor-like genes HTR3C,HTR3D and HTR3E[J].Gene,2003,310:101–111.
[20]Karnovsky,A.M. etal.A cluster of novel serotonin receptor 3-like genes on human chromosome 3[J].Gene,2003,319:137–148.
[21]Maricq AV,Petemon AS,Brake AJ eta1.Primary structure and functional expression of the 5HT3 receptor,a serotonin-gated ion channel[J].Science,1991,254(5030):432-437.
[22]MICQ A V, PETERSON A S,BRAKE A J eta1.Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel[J].Science,1991, 254:432-437.
[23]Davies PA,PistisM,HannaMC et a1.The 5-HT3B subunit is a major determinant of seroton in receptor function[J].Nature,1999,397(6717):359-363.
[24]Adrienne E.Dubin,Rene Huvar,Michael R.D’Andrea etal. The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a5-HT3B Receptor Subunit[J]. The American Society for Biochemistry and Molecular Biology,Inc,1999,274(43):30799-30810.
[25]Frank B,Niesler B,Nothen MM etal.Investigation of the human seroton in receptor gene HTR3B in bipolar affective and schizophrenic patients[J].Am J Med Genet B Neuropsychiatr Genet,2004,131B(1)1–5.
[26]Tremblay P.B,Kaiser R,Sezer O etal.Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients[J].J Clin Oncol,2003,21(11):2147–2155.
[27]Reeves DC,Lummis SC.The molecular basis of the structure and function of the 5-HT3 receptor:a model ligand-gated ion channel[J].Mol Membr Biol,2002,19:11–26.
[28]BeateNiesler,JuttaWalstab,SandraCombrink.Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D,and 5-HT3E[J]. Mol Pharmacol,2007,72(1):8–17.
[29]Sterling N.Sudweeks,,Johannes A.van Hooft,Jerrel L. Yakel.Serotonin 5-HT3 receptors in rat CA1 hippocampal interneurons: functional and molecular characterization[J]. The Physiological Society,2002,544(3):715-726.
[30]Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting[J].Br J Anaesth.,1992,69(7 ):60S-62S.
[31] PiercePA,xieGx,LevineJD etal.5-Hydroxytryptamine receptor subtype messenger RNAs in rat periplleral sensory and sympathetic ganglia:a polymerase chain reaetion study[J].Neuroseienee,1996,70:553-559.
[32]高纯颖,童晓青,徐峰. 5-HT3受体拮抗剂抑制化疗致吐的研究进展[J].沈阳药科大学学报,2007,24(4):254-258.
[33]Marisela Morales,Shwun-DeWang.Differential Composition of 5-Hydroxytryptamine 3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System[J]. The Journal of Neuroscience,2002, 22(15):6732–6741.
[34]LaPorteAM,FattaceiniCM.,LombardMC etal.Effeets of dorsal rhizotomy and selective lesion of serotonergiec and noradrenergic systems on 5-HT1A,5-HT1B and 5-HT3,receptors in the rats sprinal cord[J].J Neural Transm,1994,100:207-223.
[35]Kidd EJ,Laporte AM,Langloisx etal.5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and minals[J].Brain Res,1992,612:289-298.
[36]Todorovie S,Anderson EG.Serotonin Preferentially hyperpolarizes capsaicin-sensitive C type sensory neurons by activatings 5-HT1A receptors[J].Brain Res,1992,585:212-218.
[37]Riehardson BP,Engle G,Donatseh P etal.Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.Nature,1985,316:126~131.
[38]Sakurai-Yamashita Y,Yamashita K,Kaibara M etal. Differential distribution of 5-hydroxytryptamine3 receptor in the colon between human and guinea pig[J].Chin J Physiol,1999,42(3):195-198.
[39]Glatzle J,Sternini C,Robin C etal. Expression of 5-HT3 receptors in the rat gastrointestinal tract[J].Gastroenterology,2002,123(1):217-226.
[40]Claeysen S,Sebben M,Becamel C etal. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain[J].Mol Pharmacol,1999,55(5):910-920.
[41]N.Chetty,R.Chess-Williams. Demonstration of 5-HT3 receptor function and expression in the mouse bladder[J].Naunyn-Schmiedeberg’s Arch Pharmacol,2007,375:359-368.
[42]BARNES.N.M,SHARP.T.A review of central 5-HT receptors and their function[J].Neuropharmacology,1999,38:1083-1152.
[43]Edith Doucet,Alban Latremoliere,Michele Darmon etal.Immunolabelling of the 5-HT3B receptor subunit in the central and peripheral nervous systems in rodents[J]. European Journal of Neuroscience,2007,26:355-366.
[44]Monk S.A.,Desai K.,Brady C.A. etal. Generation of a selective 5-HT3B subunit-recognising polyclonal antibody;identification of immunoreactive cells in rat hippocampus[J].Neuropharmacology,2001, 41:1013-1016.
[45]Reeves,D.C.,Lummis,S.C. Detection of human and rodent 5-HT3B receptor subunits by anti-peptide polyclonal antibodies[J].BMC Neurosci,2006,29(7):27.
[46]Gehlert D.R.,Gackenheimer S.L.,Wong D.T. etal.Localization of 5-HT3 receptors in the rat brain using[3H]LY278584[J]. Brain Res,1991,553:149e154.
[47]Laporte A.M.,Koscielniak T.,Ponchant M. etal.Quantitative autoradiographic mapping of5-HT3 receptors in the rat CNS using [125I] iodo-zacopride and [3H] zacoprideasradio-ligands[J].Synapse,1992, 10:271-281.
[48]Steward L.J.,West K.E.,Kilpatrick G.J. etal. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand[3H]meta-chlorophenylbiguanide[J]. Eur.J.Pharmacol,1993, 243:13-18.
[49]Parker R.M.C.,Barnes J.M.,Ge J. etal.Auto-radiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain[J]. J.Neurol.Sci,1996, 144:119-127.
[50]Mladen Vassilev Tzvetkov,Cornelia Meineke,Elke Oetjen etal. Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine[J].Gene,2007,386:52-62.
[51]CAPPELLI A,GALLELLI A,BRAILE C eta1.Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure. Effects of the quaternization of the basic nitrogen on the interaction with 5-HT3 receptor[J].Bioorg Med Chem,2002,10:2681-2691.
[52]乔明琦.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16(3):23-26.
[53]李慧,林凌云,张印南,等.抑郁模型大鼠脑内色氨酸及5-羟色胺的改变[J].中华神经科杂志,2006;39(4):233-235.
[54]Berton O , EJ Nestler. New approaches to antidepressant drug discovery : beyond monoamines[J]. Nat Rev Neurosci, 2006;7(2):137-151.
[55]Pittenger C , RS Duman. Stress , depression, and neuroplasticity : a convergence of mechanisms[J]. Neuropsychopharmacology, 2008;33(1): 88-109.
[56]Bagdy E,Solyom S,Harsing LG.Feedback stimulation of somatodendritic serotonin release:a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat[J].Brain Res Bull,1998,45:203-208.
[57]Miquel MC,Emerit MB,Nosjean A etal.Differential subcellular localization of the 5-HT3-As receptor sub-unit in the rat central nervous system[J].Eur J Neurosci,2002,15:449-457.
[58]和友,金国章.多巴胺D3受体(D3R)的神经科学新进展[J].生命科学,2005,17(2):170-175.
[59]Imperato A,Puglisi-Allegra S,Zocchi A etal.Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam[J].Eur J Pharmacol,1990,175:211-214.
[60]De Deurwaerdere P,Moison D,Navailles S etal.Regionally and functionally distinct serotonin-3 receptors control in vivo dopamine outflow in the rat nucleus accumbens[J].J Neurochem,2005.94:140-149.
[61]Kankaanpaa A,Meririnne E,Seppala T. 5-HT3 receptor antagonist MDL72222 attenuates cocaine- and mazindol-, but not methylphenidate induced neurochemical and behavioural effects in the rat[ J].Psychopharmacology,2002,159:341-350.
[62]Porras G,De Deurwaerdere P, Moison D etal.Conditional involvement of striatal serotonin 3 receptors in the control of in vivo dopamine outflow in the rat striatum[J].Eur J Neurosci,2003,17:771-781.
[63]Tsang S Y,Carl P,Xue H.Development of effective therapeutics targeting the GABAA receptor:naturally occurring alternative [J].Curr Pharmaceut Design,2004,10(9);1035-1045.
[64]Stell BM,Brickley SG,Tang CY,et al.Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors[J].Proc Natl Acad Sci USA,2003,100(24):14439-14444.
[65]Koyama S,Matsumoto N,Kubo C etal.Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons[J].J Physiol(Lond),2000,529:373-383.
[66]Puig MV,Santana N,Celada P etal.In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors[J].Cereb Cortex,2004,14:1365-1375.
[67]McMahon LL,Kauer JA.Hippocampal interneurons are excited via serotonin-gated ion channels[J].J Neurophysiol,1997,78:2493-2502.
[68]Aina Y,Susman JL.Understanding comorbidity with depression and anxiety disorders[J].J Am Osteopath Assoc,2006,106:S9-S14.
[69]Cameron OG.Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions[J].Essent Psychopharmacol,2006,7:24-34.
[70]Dolnak DR.Treating patients for comorbid depression, anxiety disorders, and somatic illnesses[J].J Am Osteopath Assoc,2006,106:S1-S8.
[71]Nutt DJ,Stein DJ.Understanding the neurobiology of comorbidity in anxiety disorders[J].CNS Spectr,2006,11:13-20.
[72]Varea E,Blasco-Ibanez JM,Gomez-Climent MA et al.Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex[J].Neuropsychopharmacology,2007,32:803-812.
[73]Mitchell EA,Pratt JA.Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat[J].Brain Res,1991,538:289-294.
[74]Becker C,Zeau B,Rivat C etal.Repeated social defeat-induced depression-like behavioural and biological alterations in rats: involvement of cholecystokinin[J].Mol Psychiatr,2008,13:1079-1092.
[75]Ramamoorthy Rajkumar,Radhakrishnan Mahesh.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target[J].Journal of Psychopharmacology,2010,24(4):455-469.